Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s):  AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.


CSE:AGN - Post by User

Post by Closure70on Apr 04, 2021 12:35pm
251 Views
Post# 32935084

Time will tell

Time will tellStarnge how a few irate, albeit, dedicated individuals continually slam this stock.  You would figure that being smarter than the average investor as they make themselves out to be that they would have either not got into a position, already have sold and made their money (because they know all the tike that mgt was crooked) or, they are adamanet to pry shares for short positions.

Doesn't take alot of thought to get such motives...definitely not coming onto boards like this to save the poor uniformed investor out of the goodness of their hearts.

My suggestion, with out air, fire gets estinguished... just soem thoughts on trying to pely and feul the rants and conspiracy theoriies.

On another note re posible funding, the price is becoming quite attractive for a major or equity company to come in on favourable terms for a phase three.  leverage on their side at this point.

Time will tell, GLTA
<< Previous
Bullboard Posts
Next >>